Palvella Therapeutics director George M. Jenkins disposes of USD 4.15 million in common shares
PVLA•Director share sales and holdings
- Palvella Therapeutics director George M. Jenkins sold 27,500 common shares on Sep. 11-15.
- The sales were priced between USD 149.38 and USD 153.10 per share.
- His directly held stake fell to 160,116 shares following the transactions.
- He also reported 13,516 shares held indirectly by a foundation.
